Minerva Neurosciences, Inc. Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain
Minerva Neurosciences, Inc. (NERV) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain of $0 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain · last filed 2026-08-07
- 2026-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $0.00.
- 2026-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $0.00.
- 2019-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $436.00.
- 2018-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $4.54K.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 |
| 2019-12-31 | $436.00 10-K · filed 2021-03-08 |
| 2018-12-31 | $4.54K 10-K · filed 2020-03-09 |
| 2018-09-30 | $22.33K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $67.42K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $173.40K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $131.03K 10-K · filed 2019-03-12 |
| 2017-09-30 | $726.00 10-Q · filed 2017-11-06 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-14 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |